121 related articles for article (PubMed ID: 38648870)
21. Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1 monolayers: a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2.
Mease K; Sane R; Podila L; Taub ME
J Pharm Sci; 2012 May; 101(5):1888-97. PubMed ID: 22359351
[TBL] [Abstract][Full Text] [Related]
22. Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines.
Wang Z; Pal D; Patel A; Kwatra D; Mitra AK
Int J Pharm; 2013 Jan; 441(1-2):40-9. PubMed ID: 23262422
[TBL] [Abstract][Full Text] [Related]
23. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.
Helms HC; Hersom M; Kuhlmann LB; Badolo L; Nielsen CU; Brodin B
AAPS J; 2014 Sep; 16(5):1046-55. PubMed ID: 24934296
[TBL] [Abstract][Full Text] [Related]
24. Modulatory Activity of the Copper Chelate, Copper N-(2-Hydroxy Acetophenone) Glycinate, in ABC-transporter-expressing Cell Lines.
Hartinger EM; Mahringer A; Choudhuri SK; Fricker G; Efferth T
Anticancer Res; 2023 Mar; 43(3):1031-1041. PubMed ID: 36854510
[TBL] [Abstract][Full Text] [Related]
25. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J
Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932
[TBL] [Abstract][Full Text] [Related]
26. Expanding the Efflux In Vitro Assay Toolbox: A CRISPR-Cas9 Edited MDCK Cell Line with Human BCRP and Completely Lacking Canine MDR1.
Wegler C; Gazit M; Issa K; Subramaniam S; Artursson P; Karlgren M
J Pharm Sci; 2021 Jan; 110(1):388-396. PubMed ID: 33007277
[TBL] [Abstract][Full Text] [Related]
27. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.
Kowalski P; Surowiak P; Lage H
Mol Ther; 2005 Apr; 11(4):508-22. PubMed ID: 15771954
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.
Miller DW; Hinton M; Chen F
Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line.
Caetano-Pinto P; Janssen MJ; Gijzen L; Verscheijden L; Wilmer MJ; Masereeuw R
Mol Pharm; 2016 Mar; 13(3):933-44. PubMed ID: 26871298
[TBL] [Abstract][Full Text] [Related]
30. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
31. Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP.
Ge S; Yin T; Xu B; Gao S; Hu M
Pharm Res; 2016 Mar; 33(3):590-602. PubMed ID: 26502886
[TBL] [Abstract][Full Text] [Related]
32. Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone.
Lagas JS; van der Kruijssen CM; van de Wetering K; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2009 Jan; 37(1):129-36. PubMed ID: 18845662
[TBL] [Abstract][Full Text] [Related]
33. Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance.
Kwatra D; Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
Int J Pharm; 2010 Aug; 395(1-2):114-21. PubMed ID: 20573570
[TBL] [Abstract][Full Text] [Related]
34. Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells.
Tan KW; Sampson A; Osa-Andrews B; Iram SH
Drug Metab Dispos; 2018 Dec; 46(12):1856-1866. PubMed ID: 30232176
[TBL] [Abstract][Full Text] [Related]
35. ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected].
Carl SM; Lindley DJ; Das D; Couraud PO; Weksler BB; Romero I; Mowery SA; Knipp GT
Mol Pharm; 2010 Aug; 7(4):1057-68. PubMed ID: 20524699
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
[TBL] [Abstract][Full Text] [Related]
37. (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
Liow JS; Zoghbi SS; Hu S; Hall MD; Hines CS; Shetty HU; Araneta MD; Page EM; Pike VW; Kreisl WC; Herscovitch P; Gottesman MM; Theodore WH; Innis RB
Neuroimage; 2016 Sep; 138():134-140. PubMed ID: 27211474
[TBL] [Abstract][Full Text] [Related]
38. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
39. Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.
Ceckova M; Reznicek J; Ptackova Z; Cerveny L; Müller F; Kacerovsky M; Fromm MF; Glazier JD; Staud F
Antimicrob Agents Chemother; 2016 Sep; 60(9):5563-72. PubMed ID: 27401571
[TBL] [Abstract][Full Text] [Related]
40. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
